On October 18-20, the “Smart Collaboration in Ba Gui: Distinguished Doctors’ Training Program” was launched in Guangxi, with opening ceremonies held at the First Affiliated Hospital of Guangxi Medical University and the Guangxi International Zhuang Medicine Hospital.
During the launch event, over 30 top medical experts from 18 prestigious institutions, including the Chinese Academy of Medical Sciences, the China Academy of Chinese Medical Sciences, Peking University People’s Hospital, the PLA General Hospital, and Peking Union Medical College Hospital, engaged in mentorship sessions with more than 200 outstanding young and mid-career doctors from Guangxi. The event also featured the unveiling of “Distinguished Doctor Workspaces” in collaboration with the First Affiliated Hospital of Guangxi Medical University and the Guangxi International Zhuang Medicine Hospital, along with on-site consultations and treatment guidance activities.
Throughout the event, the Beijing medical experts conducted in-depth research visits to the Fangchenggang Medical Innovation Empowerment Center and the Regional Medical Center. They held discussions with relevant departments of the Guangxi Zhuang Autonomous Region and Fangchenggang City regarding the construction of the Fangchenggang International Medical Open Experimental Zone, providing valuable insights and recommendations.
Officials from Guangxi stated that this initiative serves as a pivotal opportunity to strengthen the connections between exceptional specialty doctors in Guangxi and high-level medical experts from Beijing. By combining “bringing in” and “going out” strategies, a series of measures will be implemented to establish a long-term mechanism for expert guidance that will enhance Guangxi’s medical technology and bolster the healthcare workforce, ultimately contributing to the development of a healthier Guangxi.
In recent years, Guangxi has prioritized medical innovation as a fundamental support for building a comprehensive and cyclical health service system. The region has established 39 clinical medicine research centers and 53 key (nurturing) laboratories in critical areas such as thalassemia, cardiovascular and cerebrovascular diseases, and digestive disorders, while accelerating the translation of clinical research achievements. This has attracted a group of leading talents proficient in both foundational and clinical research, fostering a number of influential disciplines recognized both domestically and internationally. Additionally, the Fangchenggang International Medical Open Experimental Zone has seen the establishment of the Fangchenggang Wanquing Research Institute for Dermal and Fungal Disease Prevention and Control, effectively promoting high-quality development within the experimental area.
